Hepion Pharma reports anti-cancer activity of CRV431 in a liver cancer study in mice
17 November 2021 - 1:11AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Hepion Pharmaceuticals (NASDAQ:HEPA)
Historical Stock Chart
From Apr 2024 to May 2024
Hepion Pharmaceuticals (NASDAQ:HEPA)
Historical Stock Chart
From May 2023 to May 2024